Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Luc Wasungu"'
Drug Release by Direct Jump from Poly(ethylene-glycol-b-ε-caprolactone) Nano-Vector to Cell Membrane
Autor:
Ugo Till, Laure Gibot, Anne-Françoise Mingotaud, Jérôme Ehrhart, Luc Wasungu, Christophe Mingotaud, Jean-Pierre Souchard, Alix Poinso, Marie-Pierre Rols, Frédéric Violleau, Patricia Vicendo
Publikováno v:
Molecules, Vol 21, Iss 12, p 1643 (2016)
Drug delivery by nanovectors involves numerous processes, one of the most important being its release from the carrier. This point still remains unclear. The current work focuses on this point using poly(ethyleneglycol-b-ε-caprolactone) micelles con
Externí odkaz:
https://doaj.org/article/65d9a5e7c729471bb8dde72ed161dc42
Publikováno v:
Bioelectrochemistry. 100:36-43
New features of cell electro-permeabilization are obtained by using high field (several tens of kV/cm) with short (sub-microsecond, nanosecond) pulse duration. Arcing appears as a main safety problem when air gaps are present between electrodes. A ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5dd4a3ecc780d2f9f61183a5910b2bd
https://doi.org/10.1016/j.bioelechem.2014.06.011
https://doi.org/10.1016/j.bioelechem.2014.06.011
Autor:
Andreas Baumbach, Ravindra Kumar, Steffen Helqvist, Pieter C. Smits, Luc Wasungu, Yoshinobu Onuma, Manel Sabaté, Jan J. Piek, Patrick W. Serruys, Ad J. van Boven, Bernard Chevalier
Publikováno v:
EuroIntervention, 12(9), 1102-1107. EuroPCR
Aims The one-year randomised data of the ABSORB II trial showed that the everolimus-eluting bioresorbable scaffold and the everolimus-eluting metallic stent were comparable for the composite secondary clinical outcomes of patient-oriented composite e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9db18705699066064b51c10e4ce98a
https://pubmed.ncbi.nlm.nih.gov/27564310
https://pubmed.ncbi.nlm.nih.gov/27564310
Autor:
Lauriane Jugé, Luc Wasungu, Michel Bureau, Daniel Scherman, Marie-Pierre Rols, Nathalie Mignet
Publikováno v:
The Journal of Gene Medicine. 14:204-215
Background Electrotransfer can be obtained by the successive delivery of a high voltage short duration pulse (HV) inducing membrane destabilization and then a low voltage long duration pulse (LV), allowing DNA electrophoresis (HVLV mode). Pluronic®
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3268ebe9fd5fd85fad4ace96dc82df40
https://doi.org/10.1002/jgm.2610
https://doi.org/10.1002/jgm.2610
Publikováno v:
International Journal of Pharmaceutics. 423:7-15
Electro-gene-therapy is a promising technique for cancer treatment. However, knowledge about mechanism of gene transfer with electric field in tumor is limited. Whereas in vitro electrotransfection is efficient, gene expression in tumoral cells in vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45528b9dc92e5958aa6b12349dad8c7c
https://doi.org/10.1016/j.ijpharm.2011.04.054
https://doi.org/10.1016/j.ijpharm.2011.04.054
Autor:
Jean-Michel Escoffre, Luc Wasungu, Muriel Golzio, Justin Teissié, Thomas Portet, Chloé Mauroy, Aurelie Paganin-Gioanni, Marie-Pierre Rols
Publikováno v:
Biophysical Reviews and Letters
Biophysical Reviews and Letters, 2009, 1 (4), pp.185-191. ⟨10.1007/s12551-009-0019-2⟩
Biophysical Reviews and Letters, World Scientific Publishing, 2009, 1 (4), pp.185-191. ⟨10.1007/s12551-009-0019-2⟩
Biophysical Reviews and Letters, 2009, 1 (4), pp.185-191. ⟨10.1007/s12551-009-0019-2⟩
Biophysical Reviews and Letters, World Scientific Publishing, 2009, 1 (4), pp.185-191. ⟨10.1007/s12551-009-0019-2⟩
Gene electrotransfer can be obtained not just on single cells in diluted suspension. For more than 10 years, this is a quasi routine strategy in tissue on the living animal and a few clinical trials have now been approved. New problems have been brou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7806af8d9e07471e907dfd57d9ded8bd
https://doi.org/10.1007/s12551-009-0019-2
https://doi.org/10.1007/s12551-009-0019-2
Autor:
Marie-Pierre Rols, Justin Teissié, Jean-Michel Escoffre, Luc Wasungu, Thomas Portet, David S. Dean
Publikováno v:
Molecular Biotechnology
Molecular Biotechnology, Humana Press, 2009, 41 (3), pp.286-295. ⟨10.1007/s12033-008-9121-0⟩
Molecular Biotechnology, 2009, 41 (3), pp.286-295. ⟨10.1007/s12033-008-9121-0⟩
Molecular Biotechnology, Humana Press, 2009, 41 (3), pp.286-295. ⟨10.1007/s12033-008-9121-0⟩
Molecular Biotechnology, 2009, 41 (3), pp.286-295. ⟨10.1007/s12033-008-9121-0⟩
International audience; Cell membranes can be transiently permeabilized under application of electric pulses. This treatment allows hydrophilic therapeutic molecules, such as anticancer drugs and DNA, to enter into cells and tissues. This process, ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ce9b50b4b371a64d859457178ccc396
https://doi.org/10.1007/s12033-008-9121-0
https://doi.org/10.1007/s12033-008-9121-0
Publikováno v:
Biochemical Society Transactions, 35, 68-71. PORTLAND PRESS LTD
Cationic lipids are exploited as vectors (‘lipoplexes’) for delivering nucleic acids, including genes, into cells for both therapeutic and cell biological purposes. However, to meet therapeutic requirements, their efficacy needs major improvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ed1dcd3acd5def455391a28ab4eb21
https://doi.org/10.1042/bst0350068
https://doi.org/10.1042/bst0350068
Autor:
Patrick W, Serruys, John, Ormiston, Robert-Jan, van Geuns, Bernard, de Bruyne, Dariusz, Dudek, Evald, Christiansen, Bernard, Chevalier, Pieter, Smits, Dougal, McClean, Jacques, Koolen, Stephan, Windecker, Robert, Whitbourn, Ian, Meredith, Luc, Wasungu, Divine, Ediebah, Susan, Veldhof, Yoshinobu, Onuma
Publikováno v:
Journal of the American College of Cardiology. 67(7)
Long-term benefits of coronary stenosis treatment with an everolimus-eluting bioresorbable scaffold are unknown.This study sought to evaluate clinical and imaging outcomes 5 years after bioresorbable scaffold implantation.In the ABSORB multicenter, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::17d72c9863a3e1c63c43945d6e6315aa
https://pubmed.ncbi.nlm.nih.gov/26892412
https://pubmed.ncbi.nlm.nih.gov/26892412
Autor:
Luc Wasungu, Takashi Muramatsu, Bernard Chevalier, Dariusz Dudek, Ad J. van Boven, Shimpei Nakatani, Yohei Sotomi, Yun Kyeong Cho, Manel Sabaté, Karine Miquel-Hebert, Pannipa Suwannasom, Hector M. Garcia-Garcia, Patrick W. Serruys, Jan J. Piek, Andreas Baumbach, Maik J. Grundeken, Dougal McClean, Yuki Ishibashi, Yoshinobu Onuma, Steffen Helqvist, Manuel de Sousa Almeida
Publikováno v:
JACC-Cardiovascular interventions, 8(8), 1053-1063. Elsevier Inc.
JACC. Cardiovascular interventions, 8(8), 1053-1063. Elsevier Inc.
JACC. Cardiovascular interventions, 8(8), 1053-1063. Elsevier Inc.
OBJECTIVES This study sought to evaluate the mechanism of post-procedural cardiac biomarker (CB) rise following device implantation. BACKGROUND A fully bioresorbable Absorb scaffold, compared with everolimus-eluting metallic stents (EES), might be as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f55c3f5a7c0e399f3f90bf40b9970b47
https://pure.eur.nl/en/publications/a24e9539-479a-4712-92de-95e457d7d96b
https://pure.eur.nl/en/publications/a24e9539-479a-4712-92de-95e457d7d96b
